"Fountain of Youth" Formula Receives Fifth Patent for Increasing Growth Hormone Levels

Life Science Weekly |

By a News Reporter-Staff News Editor at Life Science Weekly -- The growth hormone revolution for women was rekindled with the following quote from Shape magazine: "When you see a 50-year-old actress who can pass for 35, you can bet that good genes aren't the only things responsible for her youthful glow." So when a study establishing the distinct ability of SeroVital(®)-hgh to naturally increase growth hormone levels without injections was published, people couldn't stop talking about it... especially when SeroVital became a focus at scientific conferences around the globe, including The 2013 Summer Meeting of the American Academy of Dermatology in New York City, Obesity Week in Atlanta, Georgia, and even the 9(th) World Congress of Cosmetic Dermatology held in Athens, Greece, to name just a few. All of that, coupled with the issuance of three separate and distinct patents from the United States Patent Office protecting the formula from imitators, has made SeroVital the number one selling "anti-aging" formula in the United States (see also SanMedica International). Because of this notoriety, SanMedica International™, SeroVital's distributor, has been very aggressive in protecting its formula. It has now received its fourth United States Patent, this time for "Methods for increasing human growth hormone levels," as well as a fifth patent for "Methods for improving health in humans." Keywords for this news article include: Patents, Dermatology, Legal Issues, Growth Hormones, Peptide Hormones, SanMedica International, Anterior Pituitary Hormones. Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

H-Source Holdings Ltd.

H-Source Holdings Inc. is a technology company operating within the healthcare industry through its subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and…

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…